Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Chemotherapy in High-Risk Breast Cancer
NCT00433511Phase 3Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Nov 2007
- Primary completion
- Jan 2014
- Countries
- 3
01
Overview
A Phase 3 trial of bevacizumab in breast cancer, sponsored by National Cancer Institute. Started Nov 2007; status: active, not recruiting.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00433511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433511.